HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yen-Chou Chen Selected Research

Nocodazole

12/2021Roles of reactive oxygen species, mitochondrial membrane potential, and p53 in evodiamine-induced apoptosis and G2/M arrest of human anaplastic thyroid carcinoma cells.
12/2019Activation of PERK Contributes to Apoptosis and G2/M Arrest by Microtubule Disruptors in Human Colorectal Carcinoma Cells ‡.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yen-Chou Chen Research Topics

Disease

18Neoplasms (Cancer)
12/2021 - 10/2002
10Colorectal Neoplasms (Colorectal Cancer)
12/2021 - 06/2004
8Glioma (Gliomas)
01/2017 - 02/2004
7Glioblastoma (Glioblastoma Multiforme)
12/2021 - 03/2008
7Breast Neoplasms (Breast Cancer)
01/2018 - 09/2007
6Inflammation (Inflammations)
04/2022 - 01/2002
6Leukemia
01/2018 - 03/2005
5Colonic Neoplasms (Colon Cancer)
12/2019 - 01/2013
4Carcinoma (Carcinomatosis)
01/2019 - 09/2004
3Infections
11/2021 - 02/2013
3Ovarian Neoplasms (Ovarian Cancer)
12/2018 - 01/2016
3Melanoma (Melanoma, Malignant)
12/2018 - 06/2011
3Carcinogenesis
03/2009 - 02/2004
2Renal Cell Carcinoma (Grawitz Tumor)
12/2021 - 01/2016
2Gliosis
10/2021 - 12/2009
2Necrosis
10/2021 - 05/2003
2Type 2 Diabetes Mellitus (MODY)
01/2021 - 10/2020
2Pulmonary Fibrosis (Fibrosing Alveolitis)
03/2019 - 10/2016
2Sexually Transmitted Diseases (Sexually Transmitted Disease)
12/2018 - 03/2016
2Lung Neoplasms (Lung Cancer)
11/2018 - 01/2018
2Hypoxia (Hypoxemia)
11/2018 - 06/2006
2Hypertension (High Blood Pressure)
01/2018 - 07/2012
2Venous Thrombosis (Deep-Vein Thrombosis)
05/2016 - 03/2016
2Hematoma
05/2013 - 07/2012
2Mitochondrial Diseases (Mitochondrial Disease)
10/2007 - 06/2005
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2022
1Anaplastic Thyroid Carcinoma
12/2021
1Traumatic Brain Injuries (Traumatic Brain Injury)
10/2021
1Brain Injuries (Brain Injury)
10/2021
1Acne Vulgaris
05/2021
1Liver Neoplasms (Liver Cancer)
02/2021

Drug/Important Bio-Agent (IBA)

23Proteins (Proteins, Gene)FDA Link
12/2019 - 06/2002
12Reactive Oxygen Species (Oxygen Radicals)IBA
04/2022 - 04/2005
8Caspase 3 (Caspase-3)IBA
02/2021 - 06/2002
8DNA (Deoxyribonucleic Acid)IBA
01/2019 - 05/2003
6pyrazolanthroneIBA
12/2019 - 12/2010
6EnzymesIBA
12/2018 - 02/2005
6Prostaglandins EIBA
08/2012 - 01/2002
5evodiamineIBA
12/2021 - 01/2014
4Imatinib Mesylate (Gleevec)FDA Link
01/2022 - 06/2011
4PeroxidesIBA
01/2019 - 06/2006
4fisetinIBA
02/2014 - 06/2002
4Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2014 - 05/2008
4Heme Oxygenase-1IBA
01/2014 - 06/2004
4wogoninIBA
11/2010 - 06/2002
4QuercetinIBA
09/2008 - 02/2004
4GlycosidesIBA
11/2006 - 03/2005
3Pharmaceutical PreparationsIBA
10/2020 - 02/2004
3JNK Mitogen-Activated Protein KinasesIBA
12/2019 - 01/2014
3Phosphotransferases (Kinase)IBA
03/2019 - 06/2015
3Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2019 - 01/2016
3Matrix Metalloproteinases (MMPs)IBA
01/2017 - 02/2005
3Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2014 - 01/2002
3FlavonoidsIBA
02/2013 - 11/2010
3Dinoprostone (PGE2)FDA Link
02/2013 - 10/2002
3ProstaglandinsIBA
08/2012 - 01/2002
3hydroxide ionIBA
11/2010 - 03/2005
2Paclitaxel (Taxol)FDA LinkGeneric
12/2021 - 12/2019
2NocodazoleIBA
12/2021 - 12/2019
2AntioxidantsIBA
02/2021 - 09/2008
2Cyclin B1IBA
12/2019 - 01/2017
27- methyl- 5- (1- ((3- (trifluoromethyl)phenyl)acetyl)- 2,3- dihydro- 1H- indol- 5- yl)- 7H- pyrrolo(2,3- d)pyrimidin- 4- amineIBA
12/2019 - 01/2016
2CurcuminIBA
03/2019 - 01/2014
2cobaltiprotoporphyrinIBA
01/2019 - 03/2008
2nilotinibFDA Link
12/2018 - 03/2016
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 12/2010
2Sorafenib (BAY 43-9006)FDA Link
03/2016 - 06/2015
2Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2016 - 01/2014
2Protein Kinases (Protein Kinase)IBA
01/2016 - 10/2002
2Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric
12/2014 - 02/2004
2Nitric Oxide Synthase (NO Synthase)IBA
12/2014 - 12/2010
2GossypolIBA
08/2012 - 10/2007
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
12/2010 - 02/2004
2LuteolinIBA
11/2010 - 09/2008
2kaempferolIBA
11/2010 - 09/2004
2Hydroxyl RadicalIBA
11/2010 - 09/2008
2FlavonesIBA
09/2008 - 09/2004
2Biological ProductsIBA
09/2008 - 02/2004
2baicaleinIBA
11/2006 - 10/2006
2baicalinIBA
11/2006 - 10/2006
2ChromatinIBA
06/2006 - 05/2003
2myricitrinIBA
03/2005 - 02/2005
2myricetinIBA
03/2005 - 02/2005
2flavoneIBA
09/2004 - 02/2004
2FlavanonesIBA
06/2004 - 10/2002
22'-hydroxyflavanoneIBA
06/2004 - 10/2002
2flavanoneIBA
06/2004 - 10/2002
1SpectrinIBA
10/2021
1Glial Fibrillary Acidic ProteinIBA
10/2021
1AndrogensIBA
10/2021
1Androgen Receptors (Androgen Receptor)IBA
10/2021
1Niacinamide (Nicotinamide)FDA LinkGeneric
05/2021

Therapy/Procedure

4Drug Therapy (Chemotherapy)
12/2019 - 06/2004
3Therapeutics
10/2020 - 07/2013
3Perforator Flap
11/2019 - 03/2014
3Subcutaneous Injections
01/2017 - 06/2004
2Thrombectomy
05/2016 - 03/2016
2Free Tissue Flaps
02/2016 - 07/2012
2Aftercare (After-Treatment)
12/2009 - 03/2009
1Topical Administration
05/2021